|
|
 | | | |
- close
- close
- close
- close
Wex Pharmaceutical Inc (WXI) |
QUOTE AND NEWS
Marketwire
Apr 4
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/04/11 -- WEX Pharmaceuticals Inc. (TSX: WXI) ("WEX") announces that WEX's board of directors has approved the execution of an amalgamation agreement with a wholly-owned subsidiary of Pharmagesic
Marketwire
Oct 8
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/08/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that Dr. Larry Gontovnick, WEX's Vice President, Research and Development has informed the Company of his
Marketwire
Sep 27
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/27/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that the data monitoring committee ("DMC") has undertaken its scheduled interim analysis of the Company's ongoing
Marketwire
Aug 25
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/25/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that WEX Research and Development staff and some participating clinical investigators will present a poster
Marketwire
Aug 13
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/13/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) reported events and financial results for the three-month and six-month periods ended June 30, 2010. All amounts, unless specified
Marketwire
Jul 12
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/12/10 -- WEX Pharmaceuticals Inc. (TSX: WXI) ("Wex") announced today that it has been advised of the proposal of Pharmagesic (Holdings) Inc. ("Pharmagesic"), a wholly owned subsidiary of CK Life
Marketwire
May 14
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 05/14/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) reported events and financial results for the three months ended March 31, 2010. All amounts, unless specified otherwise, are in
Marketwire
Apr 16
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/16/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that an abstract has been accepted for publication and a poster presentation at the 13th World Congress on Pain
Marketwire
Apr 5
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/05/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that Dr. Bin Huang, President and Chief Executive Officer, will present an overview of WEX Pharmaceuticals Inc. at
Marketwire
Feb 12
Comment
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/12/10 -- WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) reported major events and financial results for the nine-month period ended December 31, 2009. The Company filed a notice
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
